Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.36 USD
Change Today +0.195 / 1.75%
Volume 4.0M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Russell P. Wilson J.D.

Former Senior Vice President of Business Development, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

55$850,297
As of Fiscal Year 2014

Background*

Mr. Russell P. Wilson, also known as Rip, had been a Senior Vice President of Business Development at Novavax, Inc. since November 7, 2011. Mr. Wilson had been responsible for developing business alliances, license arrangements, and partnering opportunities with pharmaceutical companies and government agencies. He served as the Chief Financial Officer, Principal Accounting Officer and Vice President at Supernus Pharmaceuticals, Inc. since 2009 until October 2011. Mr. ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Princeton University
JD
University of Virginia
MBA
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$326,566
Total Annual Compensation$326,566

Stock Options*

All Other Compensation$5,300
Exercisable Options237,500
Unexercisable Options337,500
Total Number of Options575,000

Total Compensation*

Total Annual Cash Compensation$470,167
Total Short Term Compensation$326,566
Other Long Term Compensation$5,300
Total Calculated Compensation$850,297
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $11.36 USD +0.195

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$515.0K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
Anthony S. Marucci M.B.A.Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
$814.1K
Laurence James Neil Cooper Ph.D., M.D.Chief Executive Officer
ZIOPHARM Oncology, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.